Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1994
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.
Epistemonikos ID: a4f50121fc7bdecb6f2746dc634501e09f66de9d
First added on: May 05, 2024